| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1021479972 |
| P356 | DOI | 10.1016/J.NUCLCARD.2005.11.003 |
| P698 | PubMed publication ID | 16464725 |
| P2093 | author name string | Frank M Bengel | |
| P2860 | cites work | Smooth muscle cell proliferation index correlates with 111In-labeled antibody Z2D3 uptake in a transplant vasculopathy swine model | Q81483149 |
| Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis | Q28255335 | ||
| Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. | Q34132798 | ||
| Compensatory enlargement of human atherosclerotic coronary arteries | Q34184275 | ||
| From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. | Q35552554 | ||
| Non-invasive multislice CT coronary imaging | Q35583777 | ||
| Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates | Q35742697 | ||
| Role of endothelial dysfunction in atherosclerosis | Q35806066 | ||
| Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. | Q35943581 | ||
| The pathogenesis of coronary artery disease and the acute coronary syndromes (1). | Q36728740 | ||
| Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells | Q40830644 | ||
| Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments | Q41318509 | ||
| Frequency of sudden cardiac death and profiles of risk | Q41589898 | ||
| Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo | Q41612083 | ||
| Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). | Q43673703 | ||
| Tc-99m-labeled endothelin derivative for imaging of experimentally induced atherosclerosis | Q43687626 | ||
| Acetylated low-density lipoprotein-encapsulated cholesteryl 1,3-diiopanoate glyceryl ether for the detection of atherosclerosis in rabbits | Q44431027 | ||
| Fluorodeoxyglucose Uptake in the Aortic Wall at PET/CT: Possible Finding for Active Atherosclerosis | Q44639307 | ||
| Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque | Q44693864 | ||
| (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study | Q44964637 | ||
| Molecular imaging of atherosclerotic plaques with technetium-99m-labelled antisense oligonucleotides | Q45191220 | ||
| Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study | Q46505779 | ||
| Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography | Q46535642 | ||
| Association of vascular 18F-FDG uptake with vascular calcification. | Q46639228 | ||
| Hybrid positron detection and optical coherence tomography system: design, calibration, and experimental validation with rabbit atherosclerotic models. | Q46716159 | ||
| 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. | Q46748719 | ||
| Uptake of 111In-Z2D3 on SPECT imaging in a swine model of coronary stent restenosis correlated with cell proliferation. | Q47207679 | ||
| Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo | Q47310860 | ||
| Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo | Q47658765 | ||
| Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. | Q50504673 | ||
| Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. | Q50507177 | ||
| 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. | Q53578981 | ||
| Ex vivo coronary atherosclerotic plaque characterization with multi-detector-row CT. | Q53654999 | ||
| Composition of coronary atherosclerotic plaques in patients with acute myocardial infarction and stable angina pectoris determined by contrast-enhanced multislice computed tomography. | Q53656943 | ||
| Coronary Magnetic Resonance Angiography for the Detection of Coronary Stenoses | Q56422767 | ||
| Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging | Q56986951 | ||
| Non-invasive imaging of glycoprotein VI binding to injured arterial lesions | Q60607039 | ||
| Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging | Q73209063 | ||
| Clinical images from intravascular ultrasound: coronary disease, plaque rupture, and intervention--the inside view | Q77122119 | ||
| Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography | Q78757217 | ||
| Imaging of unstable atherosclerotic lesions | Q80796551 | ||
| P433 | issue | 1 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 111-118 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Journal of Nuclear Cardiology | Q609415 |
| P1476 | title | Atherosclerosis imaging on the molecular level | |
| P478 | volume | 13 |
| Q53483221 | A rabbit model of atherosclerosis at carotid artery: MRI visualization and histopathological characterization. |
| Q53247167 | Assessment of atherosclerotic plaques in a rabbit model by delayed-phase contrast-enhanced CT angiography: comparison with histopathology. |
| Q36777401 | Design of targeted cardiovascular molecular imaging probes |
| Q36657912 | Imaging atherosclerosis in the vulnerable patient |
| Q37277958 | Integrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patients. |
| Q37177648 | Molecular imaging will replace perfusion imaging: The impossible dream |
| Q37200626 | Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC). |
| Q36632443 | What are the most useful and trustworthy noninvasive anatomic markers of existing vascular disease? |
Search more.